08:00 , Nov 25, 2013 |  BC Week In Review  |  Company News

Avesthagen, Elpen Pharmaceutical Co. Inc. sales and marketing update

Avesthagen granted rights to Elpen to distribute biosimilar Avdesp in Greece, Cyprus, Bulgaria, Romania, Croatia, Slovenia, Slovakia, Serbia, Bosnia, Albania, Macedonia, Montenegro and Kosovo. Avdesp is a biosimilar of anemia drug Aranesp darbepoetin alfa, a...
07:00 , Mar 28, 2011 |  BC Week In Review  |  Company News

Avesthagen sales and marketing update

Avesthagen launched its Whole Genome Scanning service in India. The service, which uses technology from Affymetrix Inc. (NASDAQ:AFFX, Santa Clara, Calif.), is available directly to consumers for $1,000. Avesthagen Ltd. , Bangalore, India   Business:...
07:00 , Mar 28, 2011 |  BioCentury  |  Finance

Highlights of weekly biotech stock moves

Regulatory milestones Bristol-Myers Squibb Co. (NYSE: BMY) gained $1.56 to $27.29 last week after FDA approved a BLA for IV Yervoy ipilimumab as first-line therapy for unresectable or metastatic melanoma. The approval includes a REMS...
00:38 , Mar 24, 2011 |  BC Extra  |  Company News

Avesthagen launches whole genome sequencing service

Avesthagen Ltd. (Bangalore, India) launched its Whole Genome Scanning service in India. The service, which uses technology from Affymetrix Inc. (NASDAQ:AFFX), is available directly to consumers for $1,000. Affymetrix was up $0.07 to $4.52 on...
08:00 , Dec 20, 2010 |  BC Week In Review  |  Clinical News

Avdesp: Phase III start

Next quarter, Avesthagen will begin a double-blind, active-controlled, Indian Phase III trial of Avdesp. Avesthagen Ltd. , Bangalore, India   Product: Avdesp   Business: Hematology   Molecular target: NA   Description: Biosimilar of darbepoetin alfa,...
08:00 , Dec 20, 2010 |  BC Week In Review  |  Clinical News

Avdesp: Phase III start

Next quarter, Avesthagen will begin a double-blind, active-controlled, Indian Phase III trial of Avdesp. Avesthagen Ltd. , Bangalore, India   Product: Avdesp   Business: Hematology   Molecular target: NA   Description: Biosimilar of darbepoetin alfa,...
07:00 , May 14, 2007 |  BC Week In Review  |  Company News

Avestha, Manipal AcuNova Ltd. deal

The companies partnered to develop diagnostics and perform contract research. For diagnostics, Avestha will use its SNP analysis technology to develop molecular diagnostics for all indications and use systems biology to identify novel biomarkers for...
07:00 , Apr 2, 2007 |  BC Week In Review  |  Company News

Avestha deal

Avestha started the Avestagenome project to build a genetic, genealogical and medical database of about 69,000 Parsi Zoroastrians, an inbred population in India. Avestha plans to use the database to identify genes that cause breast...
08:00 , Jan 29, 2007 |  BioCentury  |  Strategy

Outsourcing money

Avestha Gengraine Technologies Pvt. Ltd. intends to tap into both Indias traditional medicines heritage, and the international contacts of its founder and managing director Villoo Morawala Patell to become a global biotech company. With no...
01:43 , Jan 25, 2007 |  BC Extra  |  Financial News

Avestha raises EUR 25 million

Systems biology company Avestha (Bangalore, India) raised EUR 25 million ($32.4 million) in a series C round. Fidelity International; Limagrain; Daninvest; and Bennett Coleman participated in the round. Avestha , which said it is valued...